Drug Database
Back to search

France· FR:69893582

LOXAPAC 100 mg, comprimé pelliculé

A loxapine product containing succinate de loxapine, registered in France by CNX THERAPEUTICS FRANCE, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N05AH01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLOXAPAC 100 mg, comprimé pelliculéATCN05AH01REGISTER NO.FR:69893582PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about succinate de loxapineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Loxapine is registered in 12 of 19 countries.

Countries holding a registration under ATC N05AH01 (loxapine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose
Search loxapine products by name

Loxapine · ATC N05AH01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of loxapine costs, country by country.

Normalised to the WHO defined daily dose (9.1 mg), so markets compare like for like.

  • France: $0.043 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Loxapine · price per daily dose (9.1 mg)

USD · FX 28 Sept 2026

  • FR France$0.043
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SUCCINATE DE LOXAPINE
Manufacturer
CNX THERAPEUTICS FRANCE
Country
France (FR)
ATC code
N05AH01
ATC class
Loxapine
Defined daily dose
9.1 mg, Inhal
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

1 priced
  • cip13
    3400933984281
    plaquette(s) PVC-Aluminium de 30 comprimé(s)
    EUR 12.32
  • cip13
    3400958486111
    plaquette(s) PVC-Aluminium prédécoupées de 30 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

122 interactions on record for loxapine.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check loxapine against other medicinesHow interaction checks work

Loxapine · interactions on record

122 records

  • 12 severe
  • 97 moderate
  • 1 minor
  • 12 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Loxapine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All loxapine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Adasuve
  • Liechtenstein · Adasuve
  • Norway · Adasuve

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c2fa0320-7ba2-4ef0-84c2-9dc7475f8b02
GET /v1/drugs/c2fa0320-7ba2-4ef0-84c2-9dc7475f8b02?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69893582",
  "date_amm": "1995-06-14",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SUCCINATE DE LOXAPINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about loxapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console